EUVIMEDEUVIMED entdecken
Crossref

Local therapy to recurrent/metastatic foci augments the benefit of immune checkpoint inhibitors in nasopharyngeal carcinoma

Xueqin Chen, Lin Zhu, Jie Chen, Wei Qian, Peiyao Liu, Tingting Xu, Chunying Shen, Dongmei Ji, Chaosu Hu, Xueguan Lu, Xin Zhou

European Journal of Cancer · 2026

DOI: 10.1016/j.ejca.2026.117014 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Cancer, 2026. Verfasst von Xueqin Chen und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai 200032, China; Department of Oncology, Shanghai Medical College, …. Hauptthemen laut MEDLINE: Immune Checkpoint Inhibitors, Nasopharyngeal Neoplasms, Nasopharyngeal Carcinoma, Neoplasm Recurrence, Local. Die Arbeit nennt 43 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Immune Checkpoint InhibitorsNasopharyngeal NeoplasmsNasopharyngeal CarcinomaNeoplasm Recurrence, LocalHumansFemaleRetrospective StudiesMaleMiddle AgedAdultAgedImmunotherapy

Stichwörter der Autor:innen

Immune checkpoint inhibitorLocal therapy combined with immunotherapyRecurrent or metastatic nasopharyngeal carcinoma

Substanzen

Immune Checkpoint Inhibitors

Autor:innen und Institutionen

  • Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai 200032, China; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, China; Shanghai Clinical Research C…
  • Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, China; Department of Head & Neck Medical Oncology, Fudan University Shanghai Cancer, Shanghai, China.

Zitieren

APA

Chen, X., Zhu, L., Chen, J., Qian, W., Liu, P., Xu, T., Shen, C., Ji, D., Hu, C., Lu, X., & Zhou, X. (2026). Local therapy to recurrent/metastatic foci augments the benefit of immune checkpoint inhibitors in nasopharyngeal carcinoma. European Journal of Cancer. https://doi.org/10.1016/j.ejca.2026.117014

Vancouver

Chen X, Zhu L, Chen J, Qian W, Liu P, Xu T, et al. Local therapy to recurrent/metastatic foci augments the benefit of immune checkpoint inhibitors in nasopharyngeal carcinoma. European Journal of Cancer. 2026. doi:10.1016/j.ejca.2026.117014

BibTeX
@article{Chen2026,
  author = {Chen, Xueqin and Zhu, Lin and Chen, Jie and Qian, Wei and Liu, Peiyao and Xu, Tingting and Shen, Chunying and Ji, Dongmei and Hu, Chaosu and Lu, Xueguan and Zhou, Xin},
  title = {Local therapy to recurrent/metastatic foci augments the benefit of immune checkpoint inhibitors in nasopharyngeal carcinoma},
  journal = {European Journal of Cancer},
  year = {2026},
  doi = {10.1016/j.ejca.2026.117014}
}
Kostenlos starten →